-
Signature
-
/s/ Jillian Forusz, as attorney-in-fact
-
Stock symbol
-
ADBE
-
Transactions as of
-
Mar 15, 2024
-
Transactions value $
-
-$257,189
-
Form type
-
4
-
Date filed
-
3/19/2024, 04:57 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+458 |
+11.24% |
$0.00 |
4.53K |
Mar 15, 2024 |
Direct |
F1 |
| transaction |
ADBE |
Common Stock |
Tax liability |
-$112K |
-227 |
-5.01% |
$492.46 |
4.3K |
Mar 15, 2024 |
Direct |
F2 |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+62 |
+1.44% |
$0.00 |
4.37K |
Mar 15, 2024 |
Direct |
|
| transaction |
ADBE |
Common Stock |
Tax liability |
-$14.8K |
-30 |
-0.69% |
$492.46 |
4.34K |
Mar 15, 2024 |
Direct |
F2 |
| transaction |
ADBE |
Common Stock |
Sale |
-$131K |
-263 |
-6.07% |
$496.68 |
4.07K |
Mar 18, 2024 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-458 |
-19.98% |
$0.00 |
1.83K |
Mar 15, 2024 |
Common Stock |
458 |
$0.00 |
Direct |
F4 |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-62 |
-20% |
$0.00 |
248 |
Mar 15, 2024 |
Common Stock |
62 |
$0.00 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: